I agree that this site is using cookies. You can find further informations here.
X
Vanderlinden, Aurelie
14  results:
Search for persons X
?
1

Development and Optimisation of Tumour Treating Fields (TTF..:

Jones, Callum G. ; Vanderlinden, Aurelie ; Rominiyi, Ola.
Cancers.  16 (2024)  5 - p. 863 , 2024
Link: https://doi.org/10.3390/..
 
?
2

Inhibition of ATR opposes glioblastoma invasion through dis..:

Derby, Sarah J ; Dutton, Louise ; Strathdee, Karen E...
Neuro-Oncology.  26 (2023)  4 - p. 625-639 , 2023
Link: https://doi.org/10.1093/..
 
?
3

DNA damage response inhibitors enhance tumour treating fiel..:

Vanderlinden, Aurelie ; Jones, Callum G. ; Myers, Katie N...
British Journal of Cancer.  129 (2023)  11 - p. 1829-1840 , 2023
Link: https://doi.org/10.1038/..
 
?
4

TUMOUR TREATING FIELDS WITH DDR INHIBITORS EFFECTIVELY LEAD..:

Jones, Callum ; Vanderlinden, Aurelie ; Myers, Katie...
Neuro-Oncology.  25 (2023)  Supplement_3 - p. iii11-iii11 , 2023
Link: https://doi.org/10.1093/..
 
?
5

DNAR-12. COMBINING TUMOUR TREATING FIELDS WITH THERAPEUTIC ..:

Vanderlinden, Aurelie ; Rominiyi, Ola ; Collis, Spencer...
Neuro-Oncology.  24 (2022)  Supplement_7 - p. vii93-vii93 , 2022
Link: https://doi.org/10.1093/..
 
?
6

Identification and Validation of ERK5 as a DNA Damage Modul..:

Carmell, Natasha ; Rominiyi, Ola ; Myers, Katie N....
Cancers.  13 (2021)  5 - p. 944 , 2021
Link: https://doi.org/10.3390/..
 
?
7

Correction: Tumour treating fields therapy for glioblastoma..:

Rominiyi, Ola ; Vanderlinden, Aurelie ; Clenton, Susan Jane...
British Journal of Cancer.  125 (2021)  4 - p. 623-623 , 2021
Link: https://doi.org/10.1038/..
 
?
8

Tumour treating fields therapy for glioblastoma: current ad..:

Rominiyi, Ola ; Vanderlinden, Aurelie ; Clenton, Susan Jane...
British Journal of Cancer.  124 (2020)  4 - p. 697-709 , 2020
Link: https://doi.org/10.1038/..
 
?
9

TMOD-39. EX-VIVO 3-DIMENSIONAL MODELS OF POST-SURGICAL RESI..:

Rominiyi, Ola ; Myers, Katie ; Vanderlinden, Aurelie...
Neuro-Oncology.  21 (2019)  Supplement_6 - p. vi271-vi271 , 2019
Link: https://doi.org/10.1093/..
 
?
10

Identification and Validation of ERK5 as a DNA Damage Modul..:

Carmell, Natasha ; Rominiyi, Ola ; Myers, Katie N...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7956595/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
11

Correction: Tumour treating fields therapy for glioblastoma..:

Rominiyi, Ola ; Vanderlinden, Aurelie ; Clenton, Susan Jane...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8368194/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
12

Identification and Validation of ERK5 as a DNA Damage Modul..:

Carmell, Natasha ; Rominiyi, Ola ; Myers, Katie N...
Carmell , N , Rominiyi , O , Myers , K N , McGarrity-Cottrell , C , Vanderlinden , A , Lad , N , Perroux-David , E , Sherif , A , Fernando , M , Finegan , K , Brown , S & Collis , S 2021 , ' Identification and Validation of ERK5 as a DNA Damage Modulating Drug Target in Glioblastoma ' , Cancers , vol. 13 , no. 5 , 944 , pp. 1-14 . https://doi.org/10.3390/cancers13050944.  , 2021
Link: https://research.manches..
 
?
13

Identification and Validation of ERK5 as a DNA Damage Modul..:

Natasha Carmell ; Ola Rominiyi ; Katie N. Myers...
https://www.mdpi.com/2072-6694/13/5/944.  , 2021
Link: https://doi.org/10.3390/..
 
?
14

Identification and Validation of ERK5 as a DNA Damage Modul..:

Natasha Carmell ; Ola Rominiyi ; Katie N. Myers...
Molecular Cancer Biology.  , 2021
Link: https://doi.org/10.3390/..
 
1-14